By a News Reporter-Staff News Editor at Diabetes Week -- Joslin Diabetes Center announced that Tandem Diabetes CareŽ, Inc., a medical device company that designs and manufactures products for people with insulin-dependent diabetes, has joined the Joslin Institute for Technology Translation (the "Institute" or JITT) as a Founding Member and is a member of its Advisory Board. A new department of Joslin Diabetes Center, the Joslin Institute for Technology Translation is focused on leveraging the potential of technology with the introduction of clinical solutions and digital health to improve the lives of people with diabetes (see also Joslin Diabetes Center).
"Insulin pumps play a large role in diabetes technology innovation," said Howard Wolpert, MD, Director of JITT. "Our patients are interested in developing pump technologies. We are pleased to have Tandem Diabetes Care as a JITT Founding Member and we welcome the opportunities for advancing patient care that this collaboration will bring."
"As a Founding Member of the JITT, Tandem is excited to collaborate with Joslin to provide new technologies for diabetes management," said Kim Blickenstaff, president and CEO, Tandem Diabetes Care, Inc. "This relationship will further our mission to develop innovative, user-centric diabetes devices that provide benefit to people with diabetes and health care providers alike." Joslin Diabetes Center does not promote or endorse any product. Revenue and fees from the JITT will be invested in digital health to improve patient care. About Joslin Institute for Technology Translation (JITT) Joslin Institute for Technology Translation is focused on leveraging the potential of technology with the introduction of clinical solutions and digital health to improve the lives of people with diabetes. JITT pairs Joslin Diabetes Center's clinical expertise with industry to enhance the development of new and clinically effective technologies and digital health tools; it is uniquely positioned to provide clinical insight for medical devices, technologies and strategies for cost-efficient solutions that improve diabetes care and outcomes. About Joslin Diabetes Center Joslin Diabetes Center, based in Boston, Massachusetts, is committed to advancing diabetes research, clinical care, education and health and wellness programs on a global scale. Joslin is dedicated to ensuring that people with diabetes live long, healthy lives and offers real progress in preventing and curing diabetes. Joslin is an independent, nonprofit institution affiliated with Harvard Medical School, and is recognized worldwide for driving innovative solutions in diabetes prevention, research, education, and care. Its mission is to prevent, treat and cure diabetes and the organization's vision is a world free of diabetes and its complications. For more information, visit www.joslin.org. About Tandem Diabetes Care, Inc.Tandem Diabetes Care, Inc. is a medical device company with an innovative, user-centric and integrated approach to the design, development and commercialization of products for people with insulin-dependent diabetes. The Company manufactures and sells the t:slimŽ Insulin Pump, the slimmest and smallest durable insulin pump currently on the market, and the first and only insulin pump with a high resolution, color touch screen. Tandem is based in San Diego, California. For more information, visit www.tandemdiabetes.com.
Keywords for this news article include: Technology, Joslin Diabetes Center.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC